Difference between revisions of "40S ribosomial protein SA"
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | |||
| − | |||
| − | |||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 47: | Line 44: | ||
| | | | ||
|- | |- | ||
| − | |||
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 10:03, 10 March 2015
| Substrate peptide name | 40S ribosomial protein SA |
| Synonyms | Colon carcinoma laminin-binding protein
Multidrug resistance-associated protein MGr1-Ag |
| Determination type | In situ/In vitro |
| Source | Homo sapiens |
| Subcellular localization | Cytosol |
| Swissprot ID | P08865 |
| Reactive glutamines | Not determined yet |
| Reactive lysines | Not determined yet |
| Substrate sequence | - |
| Structure | No available crystal structure |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:12799366 |
| Notes |
